Skip to main content
. 2019 May 9;104(12):2400–2409. doi: 10.3324/haematol.2018.200220

Table 3.

Multivariate analysis of somatic variants with Sokal score, European Treatment and Outcome Study long-term survival (ELTS) score and BCRABL1 transcript type in the imatinib cohort for cumulative incidence of 3-log reduction in BCRABL1 transcripts from baseline (MR3) (by the Fine-Gray model) and probabilities of event-free survival (EFS), progression-free survival (PFS) and chronic myeloid leukemia (CML)-related survival (by the Cox proportional hazard regression model).

graphic file with name 1042400.tab3.jpg